Investor mix
7 investors on record; lead investors include Emerging Technology Partners, Jiangxi Kangdao Biological, CCB Financial Assets Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Other / undisclosed | 2 | 29% |
Developer of cell therapies to treat cancer
7 investors on record; lead investors include Emerging Technology Partners, Jiangxi Kangdao Biological, CCB Financial Assets Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 43% |
| Private equity | 2 | 29% |
| Other / undisclosed | 2 | 29% |